MarketPeel
Insider Trading Intelligence
KV

Krishna Vaddi

PRLD
CEO · PRELUDE THERAPEUTICS INC · CIK 0001824633
FILING MIX · LIFETIME92%/8%
BUYS
24
SELLS
2
TOTAL VALUE
$970.8K
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
837,000
AVG SELL PX
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by Krishna Vaddi, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+66.67%+8.21%+1.01%+7.20%+4.41%
14d15+53.33%+2.96%-1.10%+4.06%+1.52%
30d15+60.00%+5.19%-0.66%+5.84%+5.87%
60d15+66.67%+7.14%+5.37%+1.77%+10.25%
90d15+53.33%+3.21%+3.79%-0.57%+10.94%
180d15+66.67%+16.64%+12.13%+4.51%+4.02%
1y15+73.33%+191.35%+20.11%+171.23%+124.13%
2y15(11 pending)+0.00%-82.91%+47.68%-130.59%-127.86%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PRLD · 837,000 shares · as of Feb 4, 2026
0499,824999,6481,499,4721,999,296202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 24 buys / 2 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
837,000837,000Feb 4, 2026Feb 5, 2026View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
675,000$0.69$467.4K1,999,296Mar 25, 2025Mar 27, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
15,000$0.73$11.0K1,324,296Mar 21, 2025Mar 24, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
5,416$0.73$4.0K1,309,296Mar 20, 2025Mar 24, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
9,106$0.75$6.8K1,303,880Mar 17, 2025Mar 18, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
29,999$0.75$22.6K1,294,774Mar 14, 2025Mar 18, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
50,000$0.72$35.8K1,264,775Mar 13, 2025Mar 14, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
47,500$0.71$33.7K1,214,775Mar 12, 2025Mar 14, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
496,000496,000Feb 4, 2025Feb 5, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
5,000$1.21$6.0K142,553Dec 31, 2024Jan 3, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
10,000$1.20$12.0K137,553Dec 30, 2024Jan 2, 2025View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
6,888$0.89$6.1K127,553Dec 19, 2024Dec 20, 2024View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
100,000$0.93$93.2K1,167,275Dec 18, 2024Dec 20, 2024View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
900$5.31$4.8K1,067,275May 25, 2023May 26, 2023View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
1,000$5.01$5.0K1,066,375May 24, 2023May 26, 2023View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
11,856$5.63$66.7K1,065,375May 23, 2023May 25, 2023View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
330,000330,000Feb 7, 2023Feb 9, 2023View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
CEO
19,188$5.13$98.4K120,665Dec 20, 2022Dec 21, 2022View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
327,900327,900Feb 15, 2022Feb 17, 2022View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,000$12.13$97.0K1,053,519Dec 13, 2021Dec 14, 2021View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
285,800285,800Jul 20, 2021Jul 22, 2021View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
President, CEO
101,477101,477Sep 29, 2020Sep 29, 2020View →
PRLD
PRELUDE THERAPEUTICS INC
SALE
President, CEO
32,8760Sep 29, 2020Sep 29, 2020View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
President, CEO
32,876551,776Sep 29, 2020Sep 29, 2020View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
President, CEO
32,876551,774Sep 29, 2020Sep 29, 2020View →
PRLD
PRELUDE THERAPEUTICS INC
SALE
President, CEO
101,4770Sep 29, 2020Sep 29, 2020View →
Other insiders · PRLD
Loading peer insiders…
About this filer
CIK 0001824633
ROLE
CEO
PRIMARY
PRLD
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001824633DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback